• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Charm Therapeutics

To add a bio or update company history, please click update information.

News from Charm Therapeutics

    Charm Therapeutics raises £60m Series B led by NEA and SR One to advance next generation cancer drugCharm Therapeutics raises £60m Series B led by NEA and SR One to advance next generation cancer drug
    Charm Therapeutics
    2 Sept 2025

    Charm Therapeutics raises £60m Series B led by NEA and SR One to advance next generation cancer drug

    Charm Therapeutics develops next generation cancer drugs designed to overcome treatment resistance, using an AI driven discovery platform to identify compounds for aggressive blood cancers such as AML.

Charm Therapeutics
  • Life Sciences
  • London, United Kingdom
  • £60m
  • charmtx.com
  • Update Information

More venture news

  • BioOrbit lands a £9.8m seed round co-led by LocalGlobe and Breega to manufacture pharmaceutical drugs in space
    BioOrbit
    30 Apr 2026

    BioOrbit lands a £9.8m seed round co-led by LocalGlobe and Breega to manufacture pharmaceutical drugs in space

    SeedLife Sciences
  • Lightcast lands £20m in funding led by ARCH Venture Partners to advance single-cell analysis platform
    Lightcast
    15 Apr 2026

    Lightcast lands £20m in funding led by ARCH Venture Partners to advance single-cell analysis platform

    EquityLife Sciences
  • Helical raises a £7.5m seed round led by redalpine to build virtual labs for pharma research
    Helical
    14 Apr 2026

    Helical raises a £7.5m seed round led by redalpine to build virtual labs for pharma research

    SeedLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn